{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T06:52:02Z","timestamp":1780642322136,"version":"3.54.1"},"reference-count":39,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2014.00273","type":"journal-article","created":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T09:59:18Z","timestamp":1402480758000},"source":"Crossref","is-referenced-by-count":16,"title":["Leishmania donovani Nucleoside Hydrolase Terminal Domains in Cross-Protective Immunotherapy Against Leishmania amazonensis Murine Infection"],"prefix":"10.3389","volume":"5","author":[{"given":"Dirlei","family":"Nico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele Crespo","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iam","family":"Palatnik-de-Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Morrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Palatnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisa Beatriz","family":"Palatnik-de-Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,6,11]]},"reference":[{"issue":"Suppl S","key":"B1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1017\/S0031182006001831","article-title":"Leishmania vaccines: progress and problems","volume":"133","author":"Kedzierski","year":"2006","journal-title":"Parasitology"},{"issue":"5","key":"B2","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"B3","first-page":"251","article-title":"T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy","volume":"9","author":"Da-Cruz","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fimmu.2012.00099","article-title":"Vaccine development against Leishmania donovani","volume":"3","author":"Das","year":"2012","journal-title":"Front Immunol"},{"issue":"12","key":"B5","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1086\/588387","article-title":"Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis","volume":"197","author":"Ganguly","year":"2008","journal-title":"J Infect Dis"},{"issue":"4","key":"B6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.4269\/ajtmh.2012.12-0180","article-title":"Cytokine responses to novel antigens in a peri-urban population in Brazil exposed to Leishmania infantum chagasi","volume":"87","author":"Stober","year":"2012","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"B7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1590\/S0074-02762005000500013","article-title":"Further observations on clinical, histopathological, and immunological features of borderline disseminated cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis","volume":"100","author":"Silveira","year":"2005","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"12","key":"B8","doi-asserted-by":"publisher","first-page":"e1947","DOI":"10.1371\/journal.pntd.0001947","article-title":"IFN-\u00ce\u00b3 production to Leishmania antigen supplements the Leishmania skin test in identifying exposure to L. braziliensis infection","volume":"6","author":"Schnorr","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/1471-2334-13-529","article-title":"Immunologic response and memory T cells in subjects cured of tegumentary leishmaniasis","volume":"13","author":"Carvalho","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"11","key":"B10","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis","volume":"6","author":"Sundar","year":"2001","journal-title":"Trop Med Int Health"},{"key":"B11","doi-asserted-by":"publisher","first-page":"617521","DOI":"10.1155\/2010\/617521","article-title":"Drug resistance in visceral leishmaniasis","volume":"2010","author":"Maltezou","year":"2010","journal-title":"J Biomed Biotechnol"},{"issue":"1","key":"B12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/infdis\/160.1.104","article-title":"Immunotherapy of localized, intermediate, and diffuse forms of American cutaneous leishmaniasis","volume":"160","author":"Convit","year":"1989","journal-title":"J Infect Dis"},{"issue":"3","key":"B13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-3024.1989.tb00660.x","article-title":"Cell-mediated immunity in localized cutaneous leishmaniasis patients before and after treatment with immunotherapy or chemotherapy","volume":"11","author":"Castes","year":"1989","journal-title":"Parasite Immunol"},{"issue":"2","key":"B14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1046\/j.1365-3024.2000.00278.x","article-title":"Immunotherapy with live BCG plus heat killed Leishmania induces a T helper 1-like response in American cutaneous leishmaniasis patients","volume":"22","author":"Cabrera","year":"2000","journal-title":"Parasite Immunol"},{"issue":"1","key":"B15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1590\/S0037-86822006000100003","article-title":"Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment","volume":"39","author":"Mayrink","year":"2006","journal-title":"Rev Soc Bras Med Trop"},{"issue":"9\u00e2\u20ac\u201c10","key":"B16","first-page":"1082","article-title":"A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (S\u00c3\u00a3o Gon\u00c3\u00a7alo do Amarante, RN)","volume":"19","author":"Silva","year":"2000","journal-title":"Vaccine"},{"issue":"39","key":"B17","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1016\/j.vaccine.2008.07.029","article-title":"Immunogenicity assay of the Leishmune\u00c2\u00ae vaccine against canine visceral leishmaniasis in Brazil","volume":"26","author":"Borja-Cabrera","year":"2008","journal-title":"Vaccine"},{"issue":"6","key":"B18","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1586\/14760584.7.6.833","article-title":"The FML-vaccine against canine visceral leishmaniasis: from the second generation to the synthetic vaccine","volume":"7","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"13","key":"B19","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1016\/j.vaccine.2005.11.061","article-title":"The FML-vaccine (Leishmune\u00c2\u00ae) against canine visceral leishmaniasis: a transmission blocking vaccine","volume":"24","author":"Saraiva","year":"2006","journal-title":"Vaccine"},{"issue":"27","key":"B20","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1016\/j.vaccine.2009.03.045","article-title":"Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune\u00c2\u00ae in Brazilian endemic areas","volume":"27","author":"Palatnik-de-Sousa","year":"2009","journal-title":"Vaccine"},{"issue":"18","key":"B21","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.vaccine.2008.02.044","article-title":"Despite Leishvaccine and Leishmune trigger distinct immune profiles, their ability to activate phagocytes and CD8+ T-cells support their high-quality immunogenic potential against canine visceral leishmaniasis","volume":"26","author":"Ara\u00c3\u00bajo","year":"2008","journal-title":"Vaccine"},{"issue":"7","key":"B22","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.vaccine.2008.11.104","article-title":"T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune","volume":"27","author":"Ara\u00c3\u00bajo","year":"2009","journal-title":"Vaccine"},{"issue":"1\u00e2\u20ac\u201c2","key":"B23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.vetimm.2011.02.007","article-title":"Immunological changes in canine peripheral blood leukocytes triggered by immunization with first or second generation vaccines against canine visceral leishmaniasis","volume":"141","author":"Ara\u00c3\u00bajo","year":"2011","journal-title":"Vet Immunol Immunopathol"},{"issue":"20","key":"B24","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/S1359-6446(03)02864-2","article-title":"Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity","volume":"8","author":"Marciani","year":"2003","journal-title":"Drug Discov Today"},{"issue":"17\u00e2\u20ac\u201c18","key":"B25","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1016\/j.vaccine.2003.11.039","article-title":"Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine","volume":"22","author":"Borja-Cabrera","year":"2004","journal-title":"Vaccine"},{"issue":"33","key":"B26","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1016\/j.vaccine.2007.06.005","article-title":"Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune vaccine","volume":"25","author":"Santos","year":"2007","journal-title":"Vaccine"},{"issue":"3\u00e2\u20ac\u201c4","key":"B27","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.vetimm.2009.12.008","article-title":"Diminished CD4+\/CD25+ T cell and increased IFN-gamma levels occur in dogs vaccinated with Leishmune in an endemic area for visceral leishmaniasis","volume":"135","author":"de Lima","year":"2010","journal-title":"Vet Immunol Immunopathol"},{"issue":"3","key":"B28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.vaccine.2009.09.071","article-title":"Immunotherapy with the saponin enriched-Leishmune vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis","volume":"28","author":"Borja-Cabrera","year":"2010","journal-title":"Vaccine"},{"issue":"18","key":"B29","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1016\/j.vaccine.2006.02.034","article-title":"Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis","volume":"24","author":"Oliveira-Freitas","year":"2006","journal-title":"Vaccine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/1475-2875-10-224","article-title":"Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S\/AS01 malaria vaccine in children across diverse transmission settings in Africa","volume":"10","author":"Leach","year":"2011","journal-title":"Malar J"},{"issue":"10","key":"B31","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S1473-3099(11)70100-1","article-title":"Safety and efficacy of the RTS,S\/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial","volume":"11","author":"Asante","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1056\/NEJMoa1208394","article-title":"A phase 3 trial of RTS,S\/AS01 malaria vaccine in African infants","volume":"367","author":"Agnandji","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"B33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1590\/S0037-86821996000200008","article-title":"The FML (fucose mannose ligand) of Leishmania donovani: a new tool in diagnosis, prognosis, transfusional control and vaccination against human kala-azar","volume":"29","author":"Palatnik de Sousa","year":"1996","journal-title":"Rev Soc Bras Med Trop"},{"issue":"15","key":"B34","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.1021\/bi702448s","article-title":"Structural basis for substrate specificity in group I nucleoside hydrolases","volume":"47","author":"Iovane","year":"2008","journal-title":"Biochemistry"},{"issue":"6","key":"B35","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.bbapap.2009.02.011","article-title":"Crystal structures of T. vivax nucleoside hydrolase in complex with new potent and specific inhibitors","volume":"1794","author":"Vers\u00c3\u00a9es","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"B36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0166-6851(02)00010-5","article-title":"Nucleoside hydrolase from Leishmania (L.) donovani is an antigen diagnostic for visceral leishmaniasis","volume":"120","author":"Santana","year":"2002","journal-title":"Mol Biochem Parasitol"},{"issue":"22","key":"B37","doi-asserted-by":"publisher","first-page":"9375","DOI":"10.1073\/pnas.0703678104","article-title":"Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy","volume":"104","author":"Lukes","year":"2007","journal-title":"Proc Nat Acad Sci U S A"},{"issue":"7","key":"B38","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ijpara.2006.03.006","article-title":"Towards multilocus sequence typing of the Leishmania donovani complex: resolving genotypes and haplotypes for five polymorphic metabolic enzymes (ASAT, GPI, NH1, NH2, PGD)","volume":"36","author":"Mauricio","year":"2006","journal-title":"Int J Parasitol"},{"issue":"1\u00e2\u20ac\u201c2","key":"B39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0378-1119(01)00768-5","article-title":"A nonspecific nucleoside hydrolase from Leishmania donovani: implications for purine salvage by the parasite","volume":"280","author":"Cui","year":"2001","journal-title":"Gene"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T10:41:43Z","timestamp":1498128103000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2014.00273\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,11]]},"references-count":39,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2014.00273","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,11]]}}}